Novo Biosciences achieves major milestones in moving trodusquemine into clinical trials
Trodusquemine has shown promise in stimulating heart muscle regeneration in mice after an artificially induced heart attack, and slowing heart and skeletal muscle degeneration in a mouse DMD model. Novo Biosciences aims to develop a dosing regimen for juvenile DMD patients and define toxicity in juvenile animal models.